Speech learning and production in people with Parkinson's
Official title: Relationship Between Speech Perceptual Learning and Speech Production in Parkinson's Disease
Run by State University of New York at Buffalo · NCT07403539 · Data updated 2026-11-12
This project tests whether differences in how people with Parkinson's learn to hear and copy speech sounds are linked to how clearly they speak.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | State University of New York at Buffalo Academic / other |
| Locations | 1 site (Buffalo, New York) |
| Status | Recruiting |
| Started | January 27, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07403539 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are U.S. residents with a Parkinson's diagnosis who are native North American English speakers, take a levodopa-containing medication, and have no other major neurological, speech, language, or significant hearing disorders.
✕Probably not a fit
People with significant hearing loss or hearing devices, other major neurological conditions (like stroke or Alzheimer's), non–North American English speakers, or those not taking levodopa are unlikely to benefit from this specific protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional project links speech perception, perceptual learning, and speech production in people with Parkinson's using acoustic measurements. Participants complete tasks that target intensity and rate learning and discrimination while their speech is recorded and analyzed. The study enrolls native North American English speakers with Parkinson's who take levodopa, excludes people with other major neurological, speech, language, or significant hearing disorders, and is conducted at a single site. Results aim to identify predictors of individual differences in how people respond to speech-focused therapies.
Why it matters
Potential benefit: If successful, the findings could lead to more personalized therapies that help people with Parkinson's both understand speech better and speak more clearly.
How similar studies have gone: While traditional speech therapies for Parkinson's have established benefits, linking perceptual learning of speech to production outcomes is relatively novel and has limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Parkinson's disease * Native speaker of North American English * Use a drug that includes levodopa * Resident of the United States Exclusion Criteria: * Any history of language, hearing or speech disorder outside of Parkinson's disease * Other gross neurological impairment such as Alzheimer's disease or stroke * Significant hearing loss and/or use of a hearing aid or cochlear implant
Where it's running
-
State University of New York at Buffalo
Buffalo, New York, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment
This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.
-
Mental imagery with self-regulation to help daily activities in Parkinson's disease
This study tests whether a six-week program of mental imagery combined with self-regulation can help people with Parkinson’s perform daily activities better than standard learning or exercise.
-
Real-world experiences of Inbrija for Parkinson's OFF episodes
This study looks at how people with Parkinson’s who use Inbrija for OFF episodes feel and function in daily life.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Test of RO7568282 in early Parkinson's disease
This study tests whether RO7568282, compared with placebo, is safe and helps people with early Parkinson's disease who are already taking levodopa.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.